-Down to Earth Government sidelines its committee of experts to set up new panel to review India's intellectual property rights policy The politics of protecting intellectual property rights (IPR) is becoming more curiouswith the commerce ministry setting up a think tank to draft a national IPR policy while sidelining a committee of experts it had set up earlier. Annoyed academics who were asked to help formulate the policy in July this year...
More »SEARCH RESULT
Total Matching Records found : 501
Where are the jobs? -Devinder Sharma
-DNA It's a misconception that high economic growth translates into employment A recent report prepared by the consultancy firm PricewaterhouseCoopers for the Confederation of Indian Industry (CII) harps on the usual premise of boosting economic growth as the basis for job creation. Accordingly, it will still take 20 years to remove unemployment even if India grows at an annual growth rate of 9 per cent. This is exactly what we were...
More »Anand Grover, Senior advocate and former UN special rapporteur on the right to health speaks to Rema Nagarajan
-The Times of India India's intellectual property (IP) law has been hailed as one of the most progressive for safeguarding public interest, and several nations like Argentina, the Philippines and Brazil are looking to learn from it. Senior advocate and former UN special rapporteur on the right to health Anand Grover talks to Rema Nagarajan about the pressure the country is facing to change its IP laws, primarily from the US. *...
More »Lessons from Bilaspur -Gita Sen
-The Indian Express The aftermath of the terrible deaths of women who underwent sterilisation surgeries in Bilaspur in Chhattisgarh has been full of stories about what actually happened. Spurious drugs and an overenthusiastic doctor who cut corners on ensuring quality vie for immediate blame. Beyond these, many have spoken about pervasive biases of gender and caste that wreak havoc on the lives of poor women, and also of family planning policies...
More »Billing for wallet shock -Digbijay Mishra
-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...
More »
